2w1h
From Proteopedia
Line 1: | Line 1: | ||
- | + | [[Image:2w1h.png|left|200px]] | |
- | [[Image:2w1h. | + | |
<!-- | <!-- | ||
Line 10: | Line 9: | ||
{{STRUCTURE_2w1h| PDB=2w1h | SCENE= }} | {{STRUCTURE_2w1h| PDB=2w1h | SCENE= }} | ||
- | === | + | ===Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multi- targeted Kinase Inhibitor with Potent Aurora Kinase Activity=== |
Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
- | + | [[2w1h]] is a 1 chain structure of [[Cell Division Protein Kinase 2]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2W1H OCA]. | |
+ | |||
+ | ==See Also== | ||
+ | *[[Cell Division Protein Kinase 2|Cell Division Protein Kinase 2]] | ||
==Reference== | ==Reference== | ||
- | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:019143567</ref><references group="xtra"/> |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
Line 57: | Line 59: | ||
[[Category: Nucleotide-binding]] | [[Category: Nucleotide-binding]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
- | [[Category: Polymorphism]] | ||
[[Category: Serine/threonine-protein kinase]] | [[Category: Serine/threonine-protein kinase]] | ||
[[Category: Structure based drug design]] | [[Category: Structure based drug design]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
- | |||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 28 09:39:00 2009'' |
Revision as of 08:27, 16 May 2012
Contents |
Fragment-Based Discovery of the Pyrazol-4-yl urea (AT9283), a Multi- targeted Kinase Inhibitor with Potent Aurora Kinase Activity
Template:ABSTRACT PUBMED 19143567
About this Structure
2w1h is a 1 chain structure of Cell Division Protein Kinase 2 with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Howard S, Berdini V, Boulstridge JA, Carr MG, Cross DM, Curry J, Devine LA, Early TR, Fazal L, Gill AL, Heathcote M, Maman S, Matthews JE, McMenamin RL, Navarro EF, O'Brien MA, O'Reilly M, Rees DC, Reule M, Tisi D, Williams G, Vinkovic M, Wyatt PG. Fragment-based discovery of the pyrazol-4-yl urea (AT9283), a multitargeted kinase inhibitor with potent aurora kinase activity. J Med Chem. 2009 Jan 22;52(2):379-88. PMID:19143567 doi:10.1021/jm800984v
Categories: Homo sapiens | Non-specific serine/threonine protein kinase | Berdini, V. | Boulstridge, J A. | Brien, M A.O. | Carr, M G. | Cross, D M. | Curry, J. | Devine, L A. | Early, T R. | Fazal, L. | Gill, A L. | Heathcote, M. | Howard, S. | Maman, S. | Matthews, J E. | Mcmenamin, R L. | Navarro, E F. | Rees, D C. | Reilly, M O. | Reule, M. | Tisi, D. | Vinkovic, M. | Williams, G. | Wyatt, P G. | Atp-binding | Cell cycle | Cell division | Fragment screening | Kinase | Mitosis | Nucleotide-binding | Phosphoprotein | Serine/threonine-protein kinase | Structure based drug design | Transferase